Disease | non-functioning pituitary adenoma |
Comorbidity | C0020514|hyperprolactinemia |
Sentences | 1 |
PubMedID- 20963563 | Patients were divided into three groups according to treatment outcomes and pathologic results: (a) prolactinoma that responded to dopamine agonist (da) treatment (prda); (b) prolactinoma requiring surgical treatment (prs); and (c) non-functioning pituitary adenoma with hyperprolactinemia (nfpah). |
Page: 1